Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
100%(8 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_4
4
40%
Ph phase_3
2
20%
Ph not_applicable
2
20%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 44 (40.0%)
N/A2 (20.0%)

Trials by Status

unknown110%
completed880%
terminated110%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_4

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients

NCT00819637
unknownphase_4

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

NCT05173584
completednot_applicable

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

NCT02802111
completednot_applicable

COPD Assessment and Management Bundle Versus Usual Care

NCT01833026
completedphase_2

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

NCT01312961
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00819637Phase 4

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients

Terminated
NCT05173584Phase 4

Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects.

Unknown
NCT02802111Not Applicable

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

Completed
NCT01833026Not Applicable

COPD Assessment and Management Bundle Versus Usual Care

Completed
NCT01312961Phase 2

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Completed
NCT01151579Phase 4

Effect of Nebulized Bronchodilators on Heart Rate

Completed
NCT02170532Phase 4

Aerosolized Beta-Agonist Isomers in Asthma

Completed
NCT00809757Phase 3

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Completed
NCT00583947Phase 2

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects

Completed
NCT00073840Phase 3

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10